Deutsche Bank’s Takeda Pharmaceutical TAK Stock Holding History

Deutsche Bank’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.92K	Buy	+120	New	+$1.99K	﹤0.01%	3660
2023 Q2	–	Sell	-1,705	Closed	-$28.1K	–	3924
2023 Q1	$28.1K	Hold	1,705	–	–	﹤0.01%	3668
2022 Q4	$26.6K	Sell	1,705 -654	-28%	-$9.13K	﹤0.01%	3723
2022 Q3	$31K	Hold	2,359	–	–	﹤0.01%	3702
2022 Q2	$33K	Hold	2,359	–	–	﹤0.01%	3855
2022 Q1	$34K	Hold	2,359	–	–	﹤0.01%	3945
2021 Q4	$32K	Hold	2,359	–	–	﹤0.01%	4068
2021 Q3	$39K	Hold	2,359	–	–	﹤0.01%	4155
2021 Q2	$40K	Sell	2,359 -226	-9%	-$3.85K	﹤0.01%	4346
2021 Q1	$47K	Sell	2,585 -366	-12%	-$6.58K	﹤0.01%	4252
2020 Q4	$54K	Sell	2,951 -1,789	-38%	-$31.4K	﹤0.01%	4101
2020 Q3	$85K	Buy	4,740 +366	+8%	+$6.66K	﹤0.01%	3628
2020 Q2	$78K	Sell	4,374 -2,905	-40%	-$52.2K	﹤0.01%	3577
2020 Q1	$110K	Sell	7,279 -270,530	-97%	-$4.9M	﹤0.01%	3205
2019 Q4	$5.48M	Buy	277,809 +250,556	+919%	+$4.79M	﹤0.01%	1395
2019 Q3	$466K	Sell	27,253 -34,997	-56%	-$605K	﹤0.01%	2710
2019 Q2	$1.1M	Sell	62,250 -179,684	-74%	-$3.27M	﹤0.01%	2785
2019 Q1	$4.92M	Buy	+241,934	New	+$4.87M	﹤0.01%	1881

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Deutsche Bank's TAK Position: Q2 2026 in Review

Deutsche Bank opened a new position in Takeda Pharmaceutical (TAK) in Q2 2026: 120 shares worth $1.92K. The stake represents ﹤0.01% of the portfolio and ranks #3660 among its holdings. This is a return to the name: Deutsche Bank previously reported a position in TAK as recently as Q1 2023.

Deutsche Bank first reported a position in TAK in Q1 2019 and has held it in 18 quarters since. The position peaked at $5.48M in Q4 2019. 378 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

Deutsche Bank held 120 shares of Takeda Pharmaceutical worth $1.92K as of Q2 2026.
Takeda Pharmaceutical was a new Deutsche Bank position in Q2 2026.
Takeda Pharmaceutical made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #3660 holding.
Deutsche Bank first reported a position in Takeda Pharmaceutical in Q1 2019 and has held it in 18 quarters since.
Deutsche Bank's Takeda Pharmaceutical position peaked at $5.48M in Q4 2019.
378 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.